Shellback Capital LP Purchases 268,000 Shares of Bath & Body Works, Inc. $BBWI

Key Points

• Shellback Capital LP increased its holdings in Bath & Body Works by 67.0%, owning 668,000 shares after purchasing an additional 268,000 shares in the latest quarter.
• Bath & Body Works reported earnings of $0.37 per share for the last quarter, meeting analysts' expectations, with revenues of $1.55 billion.
• The company also announced a quarterly dividend of $0.20 per share, representing an annualized dividend yield of 2.7%.

Shellback Capital LP raised its stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 67.0% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 668,000 shares of the company's stock after buying an additional 268,000 shares during the quarter. Bath & Body Works comprises approximately 2.0% of Shellback Capital LP's investment portfolio, making the stock its 18th biggest holding. Shellback Capital LP owned 0.31% of Bath & Body Works worth $20,254,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the stock. SVB Wealth LLC bought a new stake in Bath & Body Works in the 1st quarter valued at $35,000. Golden State Wealth Management LLC raised its stake in shares of Bath & Body Works by 94.7% in the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock valued at $40,000 after purchasing an additional 642 shares during the period. UMB Bank n.a. lifted its holdings in shares of Bath & Body Works by 65.9% in the first quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock valued at $46,000 after purchasing an additional 596 shares in the last quarter. GKV Capital Management Co. Inc. acquired a new position in shares of Bath & Body Works during the first quarter worth about $69,000. Finally, Brooklyn Investment Group lifted its stake in Bath & Body Works by 394.9% in the 1st quarter. Brooklyn Investment Group now owns 2,697 shares of the company's stock valued at $82,000 after acquiring an additional 2,152 shares in the last quarter. Institutional investors own 95.14% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. Wall Street Zen downgraded shares of Bath & Body Works from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Piper Sandler set a $39.00 price objective on shares of Bath & Body Works and gave the stock an "overweight" rating in a research note on Thursday, May 15th. Citigroup lowered their target price on Bath & Body Works from $42.00 to $40.00 and set a "buy" rating on the stock in a research report on Tuesday, August 19th. UBS Group dropped their target price on Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating on the stock in a report on Friday, August 29th. Finally, Telsey Advisory Group restated an "outperform" rating and issued a $38.00 price target on shares of Bath & Body Works in a research note on Thursday, August 28th. Twelve analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $41.62.

Bath & Body Works Stock Performance

Shares of Bath & Body Works stock traded down $0.07 on Wednesday, hitting $28.15. The stock had a trading volume of 5,567,215 shares, compared to its average volume of 5,307,148. Bath & Body Works, Inc. has a twelve month low of $24.94 and a twelve month high of $41.87. The stock has a 50 day moving average of $30.63 and a 200 day moving average of $30.36. The firm has a market capitalization of $5.81 billion, a P/E ratio of 8.35, a PEG ratio of 0.98 and a beta of 1.49.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, meeting analysts' consensus estimates of $0.37. The business had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.55 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.Bath & Body Works's quarterly revenue was down .8% on a year-over-year basis. During the same period in the prior year, the business posted $0.37 earnings per share. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Equities analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Stockholders of record on Friday, August 22nd were issued a dividend of $0.20 per share. The ex-dividend date was Friday, August 22nd. This represents a $0.80 annualized dividend and a dividend yield of 2.8%. Bath & Body Works's dividend payout ratio is currently 23.74%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.